生物化工是21世纪的重要支柱产业之一,它结合了生物、化学和工程学的交叉学科知识,涵盖了生物化学工程与生物加工工程,同时也是生物技术的一个分支,并且被认为是化学工程前沿领域的一部分。其核心功能在于将生物技术转化为生产力,实现产业化和商品化。
生物化工产品主要以动物、植物及微生物为原料,通过生物化学工程、物理或化学的方法进行加工而成。这类产品广泛应用于医药、食品、饲料、基础有机化工原料、有机酸以及生物农药等多个领域。
该学科起源于第二次世界大战时期,标志性的事件是抗生素的深层发酵与大规模生产技术的研究。20世纪60年代末至80年代中期,转基因技术、生物催化与转化技术、动植物细胞培养技术、新型生物反应器和分离技术等的成功开发与研究,推动了学科进入新的发展阶段,并逐步完善了学科体系。进入20世纪后期,在以基因工程为代表的高新技术迅速崛起的背景下,生物化工迎来了更加广阔的发展空间。
目前,生物化工产品广泛涉及医药卫生、农林牧渔、轻工食品、化工能源及环境保护等众多领域。它不仅促进了传统产业的升级和新兴产业的诞生,而且对人类社会产生了深远的影响。据数据显示,截至2011年,全球生物高技术产品的销售额已达到1129.3亿美元,并展现出巨大的经济潜力。
随着人们对环保要求日益提高,生物化工产品因其绿色环保特性而受到广泛关注。因此,各国政府和科研人员对该领域表现出浓厚兴趣,生物化工已成为当今世界高科技竞争的重要热点之一。其发展水平被视为衡量一个国家科技实力的标志,尤其是随着生命科学领域的迅速进步,人类对更多生物高技术产品的需求日益增加。预计在未来十年内,美欧等发达国家的生物高技术产业将增长10至20倍,并相应地带动生物化工产品的快速提升。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | Dxd | 1599440-33-1 | C26H24FN3O6 |
|
—— | (1R,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-5,6-dihydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | 50648-94-7 | C27H44O4 |
|
—— | (3R,5R)-4-{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-1,3,5-trihydroxycyclohexane-1-carboxylic acid | 905-99-7 | C16H18O9 |
|
—— | <i>N</i>-carbamoyl-L-glutamic acid diethyl ester | 911658-62-3 | C10H18N2O5 |
|
—— | (4S)-4-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-6-amino-2-[[4-[[4-(dimethylamino)phenyl]diazenyl]benzoyl]amino]hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-oxo-5-[2-[(5-sulfonaphthalen-1-yl)amino]ethylamino]pentanoic acid | 730985-86-1 | C95H141N25O24S2 |
|
—— | 20-isohecogenin | 467-55-0 | C27H42O4 |
|
—— | b-D-Glucopyranoside,(3b,5a,25R)-spirostan-3-yl 2-O-b-D-glucopyranosyl- (9CI) | 41059-79-4 | C39H64O13 |
|
—— | 68-amino-36-(4-aminobutyl)-N-[1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-22,51-bis(2-amino-2-oxoethyl)-33,60-bis(3-carbamimidamidopropyl)-8,47,78-trihydroxy-13,39-bis(1-hydroxyethyl)-4,16,57,74,86,89-hexakis(hydroxymethyl)-19,42-bis[(4-hydroxyphenyl)methyl]-2,5,11,14,17,20,23,32,35,38,41,44,50,53,56,59,62,69,72,75,81,84,87,90,97-pentacosaoxo-71-[4-[6-[5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoylamino]hexanoylamino]butyl]-27,28,65,66,93,94-hexathia-3,6,12,15,18,21,24,31,34,37,40,43,49,52,55,58,61,70,73,76,82,85,88,91,96-pentacosazahexacyclo[52.37.4.225,63.06,10.045,49.076,80]heptanonacontane-30-carboxamide | 151928-23-3 | C136H207N41O46S7 |
|
—— | cis-2-hydroxy-2-phenyl-r-1-cyclohexanecarboxylic acid | 21472-50-4 | C13H16O3 |
|
—— | FMOC-TRANEXAMIC ACID | 167690-53-1 | C23H25NO4 |
|
—— | 34722-90-2 | C27H28Br2NaO5S |
|
|
—— | 11β,21-Dihydroxy-16α,17α-isopropylidendioxy-3.20-dioxo-pregnadien-(1.4) | 638-94-8 | C24H32O6 |
|
—— | 2,3,4,6-tetra-O-acetyl-ξ-D-talopyranosyl bromide | 572-09-8 | C14H19BrO9 |
|
—— | (1R,2S,4R,5R)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-ol;hydrochloride | 85700-55-6 | C8H14ClNO2 |
|
—— | cladribine | 4291-63-8 | C10H12ClN5O3 |
|
—— | L-Alanine | 56-41-7 | C3H6NO2*H |
|
—— | cyclo<->4)-<O-α-D-mannopyranosyl-(1->4)>5-O-α-D-mannopyranosyl-(1->> | 10016-20-3 | C36H60O30 |
|
—— | cyclo<->4)-<O-α-D-mannopyranosyl-(1->4)>5-O-α-D-mannopyranosyl-(1->> | 10016-20-3 | C36H60O30 |
|
—— | α-cyclodextrin | 10016-20-3 | C36H60O30 |
|
—— | 5-((9S,17R)-3,14-Dihydroxy-10-hydroxymethyl-13-methyl-hexadecahydro-cyclopenta[a]phenanthren-17-yl)-pyran-2-one | 39844-86-5 | C24H34O5 |
|
—— | Santalol, cis, alpha | 115-71-9 | C15H24O |
|
—— | ADP | 1172-42-5 | C10H13N5O10P2*2Na |
|
—— | O1,O2,O3,O4-Tetraacetyl-O6-(tri-O-acetyl-α-L-rhamnopyranosyl)-ξ-D-galactopyranose | 5239-09-8 | C26H36O17 |
|
—— | Azuleno[6,5-b]furan-2,5-dione,4-(acetyloxy)decahydro-4a,8-dimethyl-3-methylene-, (3aR,4R,4aR,7aS,8S,9aS)- | 17066-71-6 | C17H22O5 |
|
—— | Human endothelin | 117399-94-7 | C109H159N25O32S5 |
|
—— | doxycycline hydrochloride | 10592-13-9 | C22H24N2O8*ClH |
|
—— | ATP disodium salt | 606-67-7 | C10H14N5O13P3*2Na |
|
—— | methyl glycine diacetic acid trisodium salt | 164462-16-2 | C7H8NO6*3Na |
|
—— | LCZ696 | 936623-90-4 | C24H27N5O3*C24H28NO5*2H2O*3Na |
|
—— | mono-L-aspartyl chlorin e6 tetrasodium salt | 220201-34-3 | C38H37N5O9*4Na |
|
—— | Ovidonin | 28957-04-2 | C20H28O6 |
|
—— | ATRACTYLOSIDE POTASSIUM SALT | 17754-44-8 | C30H44O16S2*2K |
|
—— | pentasodium 5-phosphoribosyl-α-1-pyrophosphate | 87372-47-2 | C5H8O14P3*5Na |
|
—— | Methanaminium,N-[(dimethylamino)(3H-1,2,3-triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methyl-, hexafluorophosphate(1-) | 200731-31-3 | C10H15N6O*F6P |
|
—— | Kaur-16-en-15-one,7,20-epoxy-1,6,7,14-tetrahydroxy-, (1a,5a,6a,7b,8b,9a,10b,13b,14S)- | 28957-04-2 | C20H28O6 |
|
—— | Kaur-16-en-15-one,7,20-epoxy-1,6,7,14-tetrahydroxy-, (1a,5a,6a,7b,8b,9a,10b,13b,14S)- | 28957-04-2 | C20H28O6 |
|
—— | 4691-65-0 | C10H13N4NaO8P |
|
|
—— | GAMBOGIC ACID | 2752-65-0 | C38H44O8 |
|
—— | D-Galactose, O-β-D-galactopyranosyl-(1→4)-O-β-D-galactopyranosyl-(1→4)- | 1109-28-0 | C18H32O16 |
|
—— | 2-iodo-6-chloro-9-(β-D-ribofuranosyl)purine | 313477-85-9 | C10H10ClIN4O4 |
|
—— | dehydroepiandrosterone-17-hydrazone | 63015-10-1 | C19H30N2O |
|
—— | cholesterol | 57-88-5 | C27H46O |
|
—— | GAMBOGIC ACID | 2752-65-0 | C38H44O8 |
|
—— | glycine | 56-40-6 | C2H6NO2*Cl |
|
—— | AESCIN IB(SH) | 26339-90-2 | C55H86O24 |
|
—— | 17α-hydroxydigitoxigenin | 26629-41-4 | C23H34O5 |
|
—— | (S)-2-methyl-azetidine-1,2-dicarboxylic acid 1-(9H-fluoren-9-ylmethyl) ester | 1384745-40-7 | C20H19NO4 |
|
—— | methotrexate disodium salt | 7413-34-5 | C20H20N8O5*2Na |
|
—— | sodium,[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl [hydroxy-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphosphoryl] phosphate | 6858-46-4 | C15H22N2O17P2*2Na |
|
—— | (20S)-ginsenoside Rh2 | 67400-17-3 | C36H62O8 |
|